Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2
Cell cycle gene expression programs fuel proliferation and are universally dysregulated in cancer. The retinoblastoma (RB)-family of proteins, RB1, RBL1/p107, and RBL2/p130, coordinately represses cell cycle gene expression, inhibiting proliferation, and suppressing tumorigenesis. Phosphorylation of...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
eLife Sciences Publications Ltd
2021-12-01
|
| Series: | eLife |
| Subjects: | |
| Online Access: | https://elifesciences.org/articles/70691 |
| _version_ | 1818026715789656064 |
|---|---|
| author | Taylor P Enrico Wayne Stallaert Elizaveta T Wick Peter Ngoi Xianxi Wang Seth M Rubin Nicholas G Brown Jeremy E Purvis Michael J Emanuele |
| author_facet | Taylor P Enrico Wayne Stallaert Elizaveta T Wick Peter Ngoi Xianxi Wang Seth M Rubin Nicholas G Brown Jeremy E Purvis Michael J Emanuele |
| author_sort | Taylor P Enrico |
| collection | DOAJ |
| description | Cell cycle gene expression programs fuel proliferation and are universally dysregulated in cancer. The retinoblastoma (RB)-family of proteins, RB1, RBL1/p107, and RBL2/p130, coordinately represses cell cycle gene expression, inhibiting proliferation, and suppressing tumorigenesis. Phosphorylation of RB-family proteins by cyclin-dependent kinases is firmly established. Like phosphorylation, ubiquitination is essential to cell cycle control, and numerous proliferative regulators, tumor suppressors, and oncoproteins are ubiquitinated. However, little is known about the role of ubiquitin signaling in controlling RB-family proteins. A systems genetics analysis of CRISPR/Cas9 screens suggested the potential regulation of the RB-network by cyclin F, a substrate recognition receptor for the SCF family of E3 ligases. We demonstrate that RBL2/p130 is a direct substrate of SCFcyclin F. We map a cyclin F regulatory site to a flexible linker in the p130 pocket domain, and show that this site mediates binding, stability, and ubiquitination. Expression of a mutant version of p130, which cannot be ubiquitinated, severely impaired proliferative capacity and cell cycle progression. Consistently, we observed reduced expression of cell cycle gene transcripts, as well a reduced abundance of cell cycle proteins, analyzed by quantitative, iterative immunofluorescent imaging. These data suggest a key role for SCFcyclin F in the CDK-RB network and raise the possibility that aberrant p130 degradation could dysregulate the cell cycle in human cancers. |
| first_indexed | 2024-12-10T04:36:25Z |
| format | Article |
| id | doaj.art-7ab2a5562a954f65927013e352987cb1 |
| institution | Directory Open Access Journal |
| issn | 2050-084X |
| language | English |
| last_indexed | 2024-12-10T04:36:25Z |
| publishDate | 2021-12-01 |
| publisher | eLife Sciences Publications Ltd |
| record_format | Article |
| series | eLife |
| spelling | doaj.art-7ab2a5562a954f65927013e352987cb12022-12-22T02:01:59ZengeLife Sciences Publications LtdeLife2050-084X2021-12-011010.7554/eLife.70691Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2Taylor P Enrico0https://orcid.org/0000-0002-5453-2868Wayne Stallaert1Elizaveta T Wick2Peter Ngoi3Xianxi Wang4Seth M Rubin5https://orcid.org/0000-0002-1670-4147Nicholas G Brown6Jeremy E Purvis7https://orcid.org/0000-0002-6963-0524Michael J Emanuele8https://orcid.org/0000-0003-4104-7449Department of Pharmacology. The University of North Carolina at Chapel Hill, Chapel Hill, United States; Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill, Chapel Hill, United StatesDepartment of Genetics. The University of North Carolina at Chapel Hill, Chapel Hill, United StatesDepartment of Pharmacology. The University of North Carolina at Chapel Hill, Chapel Hill, United States; Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill, Chapel Hill, United StatesDepartment of Chemistry and Biochemistry. University of California at Santa Cruz, Santa Cruz, United StatesLineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill, Chapel Hill, United StatesDepartment of Chemistry and Biochemistry. University of California at Santa Cruz, Santa Cruz, United StatesDepartment of Pharmacology. The University of North Carolina at Chapel Hill, Chapel Hill, United States; Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill, Chapel Hill, United StatesLineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill, Chapel Hill, United States; Department of Genetics. The University of North Carolina at Chapel Hill, Chapel Hill, United StatesDepartment of Pharmacology. The University of North Carolina at Chapel Hill, Chapel Hill, United States; Lineberger Comprehensive Cancer Center. The University of North Carolina at Chapel Hill, Chapel Hill, United StatesCell cycle gene expression programs fuel proliferation and are universally dysregulated in cancer. The retinoblastoma (RB)-family of proteins, RB1, RBL1/p107, and RBL2/p130, coordinately represses cell cycle gene expression, inhibiting proliferation, and suppressing tumorigenesis. Phosphorylation of RB-family proteins by cyclin-dependent kinases is firmly established. Like phosphorylation, ubiquitination is essential to cell cycle control, and numerous proliferative regulators, tumor suppressors, and oncoproteins are ubiquitinated. However, little is known about the role of ubiquitin signaling in controlling RB-family proteins. A systems genetics analysis of CRISPR/Cas9 screens suggested the potential regulation of the RB-network by cyclin F, a substrate recognition receptor for the SCF family of E3 ligases. We demonstrate that RBL2/p130 is a direct substrate of SCFcyclin F. We map a cyclin F regulatory site to a flexible linker in the p130 pocket domain, and show that this site mediates binding, stability, and ubiquitination. Expression of a mutant version of p130, which cannot be ubiquitinated, severely impaired proliferative capacity and cell cycle progression. Consistently, we observed reduced expression of cell cycle gene transcripts, as well a reduced abundance of cell cycle proteins, analyzed by quantitative, iterative immunofluorescent imaging. These data suggest a key role for SCFcyclin F in the CDK-RB network and raise the possibility that aberrant p130 degradation could dysregulate the cell cycle in human cancers.https://elifesciences.org/articles/70691ubiquitincell cycleretinoblastomaSCFcyclin FRBL2/p130 |
| spellingShingle | Taylor P Enrico Wayne Stallaert Elizaveta T Wick Peter Ngoi Xianxi Wang Seth M Rubin Nicholas G Brown Jeremy E Purvis Michael J Emanuele Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2 eLife ubiquitin cell cycle retinoblastoma SCF cyclin F RBL2/p130 |
| title | Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2 |
| title_full | Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2 |
| title_fullStr | Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2 |
| title_full_unstemmed | Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2 |
| title_short | Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2 |
| title_sort | cyclin f drives proliferation through scf dependent degradation of the retinoblastoma like tumor suppressor p130 rbl2 |
| topic | ubiquitin cell cycle retinoblastoma SCF cyclin F RBL2/p130 |
| url | https://elifesciences.org/articles/70691 |
| work_keys_str_mv | AT taylorpenrico cyclinfdrivesproliferationthroughscfdependentdegradationoftheretinoblastomaliketumorsuppressorp130rbl2 AT waynestallaert cyclinfdrivesproliferationthroughscfdependentdegradationoftheretinoblastomaliketumorsuppressorp130rbl2 AT elizavetatwick cyclinfdrivesproliferationthroughscfdependentdegradationoftheretinoblastomaliketumorsuppressorp130rbl2 AT peterngoi cyclinfdrivesproliferationthroughscfdependentdegradationoftheretinoblastomaliketumorsuppressorp130rbl2 AT xianxiwang cyclinfdrivesproliferationthroughscfdependentdegradationoftheretinoblastomaliketumorsuppressorp130rbl2 AT sethmrubin cyclinfdrivesproliferationthroughscfdependentdegradationoftheretinoblastomaliketumorsuppressorp130rbl2 AT nicholasgbrown cyclinfdrivesproliferationthroughscfdependentdegradationoftheretinoblastomaliketumorsuppressorp130rbl2 AT jeremyepurvis cyclinfdrivesproliferationthroughscfdependentdegradationoftheretinoblastomaliketumorsuppressorp130rbl2 AT michaeljemanuele cyclinfdrivesproliferationthroughscfdependentdegradationoftheretinoblastomaliketumorsuppressorp130rbl2 |